ABSTRACT Contamination of avian attenuated vaccines by avian leukosis virus (ALV) is considered to be a specific horizontal transmission of ALV. Eradication of ALV contamination in vaccine virus seeds is thus a precondition of qualified vaccine production. In this study, we used the nucleoside reverse transcriptase (RT) inhibitor azidothymidine (AZT) together with monofactor antiserum against avian leukosis virus subgroup A (ALV-A) to remove ALV-A from vaccine virus seeds. Different doses of ALV-A were artificially added to the Newcastle disease virus (NDV) vaccine seeds, then the ALV-contaminated attenuated virus vaccine virus seeds were cultured in DF-1 cells. Single-drug treatment with 5 μg/mL AZT or 5% (v/v) as well as combined treatment with AZT and antiserum significantly suppressed ALV-A replication (P < 0.001) in the vaccine virus seeds. Complete absence of virus replication was observed in cells exposed to joint treatment with AZT and antiserum. The treated virus seeds met the requirements of the Chinese Ministry of Agriculture. Therefore, combined treatment with AZT and antiserum can be used to eradicate contaminating ALV-A from vaccine virus seeds, thus providing a new approach for improving vaccine safety.
INTRODUCTION
Avian leukemia (AL) collectively refers to a variety of benign and malignant avian neoplastic diseases caused by the avian leukosis viruses (ALVs) (Payne, 1998) . ALVs, which belong to the genus Alpharetrovirus of the Retroviridae family, cause neoplastic diseases and other reproduction problems in the poultry industry worldwide . ALV can be classified into 10 subgroups, A to J, based on the differences among viral envelope (env) proteins and viral host specificityassociated gp85 protein antigenicity (Bai et al., 1995; Chesters et al., 2002) . During the past 10 yr, ALV has been considered the main pathogen in tumor cases in different breeds of Chinese chickens. Avian leukosis virus subgroup A (ALV-A) and avian leukosis virus subgroup J (ALV-J) are the most common subgroups in China (Zhu et al., 2009 (Zhu et al., , 2010 Gao et al., 2010 Gao et al., , 2012 Lai et al., 2011; Pan et al., 2012; Dong et al., 2015) . To prevent ALV epidemics, many companies follow strict eradication programs to detoxify ALV. ALV can be transmitted horizontally and vertically, and using the attenuated virus vaccines with ALV contamination can also cause the disease transmission. Contamination incidents have frequently been reported in China and other countries, and have been causally linked to ALV-A specifically (Fadly and Garcia, 2006; Zavala and Cheng, 2006; Barbosa et al., 2008; Zhao et al., 2014) . Use of ALV-infected attenuated vaccines can cause substantial losses in chicken-breeding enterprises.
ALV contamination may come from ALV-infected chicken embryos or cells, or may be attributed to ALV contamination of vaccine virus seeds. Once virus seeds are infected with ALV, their detoxification becomes very difficult. Neutralizing antibody against ALV has been used for ALV detoxification. Since ALV and human immunodeficiency virus (HIV) are both retroviruses, and reverse transcriptase (RT) inhibitors such as azidothymidine (AZT) have been widely used for suppressing the in vivo replication of HIV (Geleziunas et al., 1993; Gray et al., 1995; Kewn et al., 1997; Akilimali et al., 2015; Nsagha et al., 2015; Okawa et al., 2015; Sripan et al., 2015) , we 629 therefore investigated the ability of similar drugs to suppress ALV replication and thereby eradicate ALV contamination in vaccine virus seeds. We compared the efficacy of single and combined treatments of AZT and anti-ALV monofactor antiserum in ALV detoxification.
MATERIALS AND METHODS

Cells, Virus, and Antibody
Endogenous avian leukosis virus subgroup E (ALV-E)-resistant DF-1 cells were purchased from ATCC (USA). The basal medium was DMEM (pH 7.2, Gibco), and 10% and 1% fetal bovine serum (Gibco) were added to the growth and maintenance media, respectively. ALV-A strain ALV-NDVP4 was isolated from contaminated Newcastle disease virus (NDV) attenuated vaccine (Zhao et al., 2014) , and allowed to proliferate in DF-1 cells. The median tissue culture infectious dose (TCID 50 ) for cells in the supernatant was measured by the Reed-Muench method . ALV-NDVP4 was inoculated into 10 specific pathogen-free (SPF) chickens, at a dose of 2000 TCID 50 per chicken. Blood sampling and serum separation were performed weekly starting 3 wk after inoculation. Antibody levels were measured using an Avian Leukosis Virus Antibody Test Kit (IDEXX). When the sample-to-positive (S/P) value reached a maximum, serum was separated after blood sampling and labeled as antiserum. The antiserum was then filtered through a 0.22 μm disposable filter and sterilized before storage at -80
• C. A series of experiments confirmed that 5% (v/v) antiserum is the best concentration for this study (prepared by the China Institute of Veterinary Drug Control). The antibody titer was calculated to be 3564.
Concentration of AZT
According to the previous study, the appropriate safe concentration of AZT used on DF-1 cells was 5 μg/mL by CCK-8 assay and statistical analysis (Su et al., 2017) .
Measuring Inhibition of ALV-A Replication in DF-1 Cells
Equal numbers of DF-1 cells were inoculated into each well of a 12-well cell culture plate. After the formation of a cell monolayer, each well was inoculated with ALV-NDVP4 at a dose of 100 TCID 50 . After 2 h, the culture medium in the wells was replaced as follows: wells 1 to 3, maintenance medium containing 5 μg/mL AZT; wells 4 to 6, maintenance medium containing 5% antiserum; wells 7 to 9, maintenance medium containing 5 μg/mL AZT and 5% antiserum; and wells 10 to 12 were used as controls for virus infection. Supernatants were collected from the wells at 3, 4, and 5 d post-inoculation with ALV-NDVP4. Levels of the ALVp27 antigen were measured using an ALV-p27 antigen ELISA detecting reagent kit (IDEXX), and the S/P value of each well was recorded. Another 2 12-well culture plates were prepared and inoculated with ALV at 1000 and 2000 TCID 50 , respectively, whereas the doses of AZT and/or antiserum remained constant.
Combined Treatment with AZT and NDVP4 Antiserum
Equal numbers of DF-1 cells were inoculated into each well of a 12-well cell culture plate. After the formation of a cell monolayer, each well was inoculated with 100 μL of NDV vaccine virus seeds contaminated with ALV-A (dose equal to 5 NDV virus seeds). After 2 h, the culture medium was replaced as follows: wells 1 to 3, maintenance medium containing 5 μg/mL AZT; wells 4 to 6, maintenance medium containing 5% antiserum added every 24 h, for 3 times; wells 7 to 9, maintenance medium containing 5 μg/mL AZT and 5% antiserum; wells 10 to 12, inoculated with contaminated NDV virus seed as controls. Supernatant was collected from each well after the NDV-induced cytopathic effect was observed. ALV-p27 antigen levels were measured using an antigen ELISA detecting reagent kit and the S/P value of each well was recorded as above. Cell supernatants from wells 1 to 12 were then inoculated into the wells of a fresh 12-well culture plate containing DF-1 cells at confluency. AZT, antiserum, or both in combination were then added, supernatant was collected after observation of the cytopathic effect, and ALV-p27 antigen levels and the S/P value of each well were recorded. NDV was propagated in culture medium containing AZT or antiserum until the ALV detection result was negative.
Detection of NDV Virus Seeds after Combined Treatment with AZT and NDVP4 Antiserum
Purified NDV vaccine virus seed was neutralized with NDV-specific antiserum before being inoculation into chicken embryo fibroblasts (CEFs) and DF-1 cells. The first passage of NDV occurred after 5 d of culture. Cell supernatants were collected after 3 passages and ALVp27 antigen levels and S/P values of each well were recorded. The vaccine was considered qualified if ALVp27 reading was negative. Contaminated and qualified NDV vaccine virus seeds were used to immunize 10 1-day-old SPF chickens each. Blood sampling and serum separation were performed every week from 3 to 8 wk after immunization. To determine the degree of purification of NDV virus seed, ALV-A antibody levels were measured using an Avian Leukosis Virus Antibody Test Kit (IDEXX). RNA was extracted from the contaminated and drug-treated NDV vaccine virus seeds, as described previously (Zhao et al., 2014) . The S/P value in cell supernatant was calculated at different times following viral inoculation. Significance values were determined by Duncan's multiple range test. Different big letters in the top right corner indicate that the differences were significant (P < 0.001); identical letters or no letters at the top right corner indicate that the differences were not significant (P > 0.001).
The mean±SD values from 3 independent experiments are shown.
Statistical Analysis
All statistical analyses were performed using SPSS statistical software package for Windows, version 17.0 (SPSS). Statistical comparisons were made by Duncan's multiple range test.
RESULTS
Inhibition of ALV-A Replication in Cells Co-treated with AZT and Antiserum
The concentrations of p27 antigen in DF-1 cells inoculated with ALV-NDVP4 were measured following single or combined treatment with AZT and/or antiserum. Both AZT and antiserum alone suppressed ALV-A replication, with AZT exhibiting a greater inhibitory effect than ALV antiserum. However, replication was further suppressed by combined treatment with AZT and antiserum even when cells were inoculated with high-dose ALV-A. When the inoculation dose was increased to 2000 TCID 50 , the S/P value in the control group, which was not treated with virus, reached 4.281, compared with 2.911 and 1.021, respectively, for the groups treated with antiserum or AZT alone, and 0.301 for the group receiving combined treatment at different time was significantly different (P < 0.001) (Table 1, Figure 1 ).
Detoxification of Vaccine Virus Seeds with ALV-A and Co-treat with AZT and Antiserum
Cytopathic effects were observed in DF-1 cells inoculated with NDV virus seed 5 d after treatment with AZT, antiserum, or both combined. At this time, the supernatant in each well was collected and p27 antigen concentration was measured. As shown in Table 2 , the concentration of ALV-p27 antigen was much lower fol- lowing joint combined treatment (P < 0.001), or with treatment with AZT or antiserum alone. Additionally, as the concentration of p27 antigen failed to reach the positive threshold of the reagent kit (S/P = 0.200) after AZT or combined treatment, these results were judged as negative, despite low values (0.023 and 0.010, respectively). The test was repeated, with similar results, suggesting that combined treatment with AZT and antiserum reduces ALV levels to below the limit of detection, whereas a low value was still observed in virus seed treated with antiserum alone. The concentration of ALV in NDV virus seed without treatment also decreased slightly as a result of NDV replication, though the results remained positive.
Detection of Purified NDV Virus Seeds
After drug treatment for 2 generations, the concentration of ALV in NDV vaccine virus seeds with antiserum alone remained very low, with an S/P value of 0.015. However, the S/P value increased to 0.147 after the virus seeds were inoculated into DF-1 cells, suggesting that ALV-A resumed replication in the absence of antiserum. In contrast, the S/P value remained at .000 5 d after inoculation of DF-1 cells with NDV vaccine virus seeds that had been treated with either AZT alone or AZT in combination with antiserum. This result was reproduced in second-passage cells, suggesting that ALV-A had been completely removed. Two purified NDV virus seeds were inoculated into SPF chickens and ALV antibody levels remained negative 3 to 8 wk after inoculation, suggesting that ALV-A contamination of the NDV vaccine virus seed had been eliminated by intervention treatment (data are not shown).
DISCUSSION
Contamination by exogenous viruses has been found in many avian attenuated vaccines over the past 20 yr. These viruses, such as ALV (Fadly and Garcia, 2006; Zavala and Cheng, 2006; Barbosa et al., 2008; Zhao et al., 2014) , reticuloendotheliosis virus (REV) (Fadly and Garcia, 2006; Awad et al., 2010; Wei et al., 2012; Li et al., 2015) , and chicken infectious anemia virus (CIAV) (Yuasa et al., 1979; Shao et al., 2012) can be transmitted vertically through chicken embryos. However, the use of ALV-contaminated attenuated vaccines is also considered an important pathway for ALV infection. Vaccine contamination with ALV, often the ALV-A specifically, has been reported frequently in China and many other countries (Fadly and Garcia, 2006; Zavala and Cheng, 2006; Barbosa et al., 2008; Zhao et al., 2014) .
ALV-free vaccine virus seed is the foundation for the production of qualified vaccines. Many virus seeds can be acquired after serial passages in chicken embryos. However, in the early stage of vaccine research in China, a shortage of SPF chicken embryos meant that ALV contamination of some vaccine virus seeds, such as those for the NDV live vaccine, could occur through chicken embryo-based attenuated passage. In a previous study, we assumed that ALV-A replication in NDV vaccine would be seriously inhibited by the cytopathic effect induced by NDV and ALV-A would thus be detoxified automatically. However, although the virus concentration decreased gradually, ALV-A retained the ability to replicate in the NDV vaccine seeds and complete self-detoxification was difficult to achieve (Table 1) . Therefore, it is difficult to eliminate the contaminating virus once the vaccine virus seed is infected with an exogenous virus such as ALV. ALV-A contamination was previously detoxified by antibody neutralization, and treatment of the ALV strains with antiserum in the present study suggested that ALV-A replication was almost totally eliminated (Table 2 ). However, this neutralization was insufficient to prevent rebound virus replication and ALV-A started to replicate in firstgeneration cultured DF-1 cells even after antiserum treatment.
ALV and HIV are retroviruses with similar genomic structures, 5 -gag-pol-env-3 , of which the pol gene encodes RT and integrase (IN, P32) in the virus core. RT has RNA-dependent and DNA-dependent polymerase activity, whereas IN is indispensable for integrating viral nucleic acid into host cells or chromosomes. Many drugs, including the widely used AZT, target RT for the control of HIV. AZT interrupts RT activity because of the similarity of its molecular structure to deoxythymidine. The absence of a hydroxyl group on the 3 end of deoxyribose means that it is unable to connect with the hydroxyl and organophosphate on the 5 end of another deoxyribose, making it difficult to form a 3,5-phosphodiester bond. As a result, the DNA strand is interrupted and HIV replication is suppressed. AZT also has an inhibiting effect on ALV-A, which is also a member of the retrovirus family. We inoculated different doses of ALV-A into DF-1 cells and demonstrated that AZT significantly inhibited ALV-A replication, and showed that this effect was strengthened by combined treatment with antiserum.
We verified the inhibitory effects of AZT and antiserum, alone or in combination, on ALV-A in NDV vaccine virus seeds. First-generation ALV-A was negative after AZT treatment, with an S/P value of 0.023, and the inhibitory effect on ALV-A was strengthened by the addition of antiserum, yielding an S/P of 0.010. This result suggested that ALV-A replication was strongly suppressed by AZT treatment, especially with the addition of antiserum. In addition, unlike after treatment with antiserum alone, ALV-A replication remained undetected in NDV vaccine virus seeds treated with AZT or with AZT and antiserum, even after inoculation and culture in DF-1 cells. Furthermore, ALV antibody levels remained negative in SPF chickens inoculated with NDV vaccine virus seeds with either of these 2 treatments, suggesting that ALV-A contamination was completely eliminated in NDV vaccine virus after ALV or ALV plus antiserum intervention treatment.
Host selection for virus culture is important. NDV and ALV-A can replicate in SPF chicken embryos as well as in CEF and DF-1 cells. However, the treatment of chicken embryos with drugs or antibodies is complex compared to the treatment of cells. In this study, we chose DF-1 instead of CEF cells because the ALV-A replication status could be determined easily through measurement of the levels of ALV-p27 antigen without potential interference from endogenous ALV. However, the time to observe a cytopathic effect of NDV virus seeds during their replication in DF-1 cells was 2 to 3 d longer than that in CEF cells, which could thus prolong the inhibitory effect of the drug and antibody on ALV replication.
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